Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vascular Solutions Approved for Device Study - Medical Product Outsourcing

What are you searching for?

Sign in

Vascular Solutions Approved for Device Study

By: Chris Trembath

NULL

Minneapolis, MN-based Vascular Solutions said it has received conditional approval from the FDA to begin testing use of its Thrombin-VSI as a component in the company’s existing hemostatic devices.
    The trial will assess the performance of Thrombin-VSI in comparison to the company’s original source of thrombin in use with the Company’s Diagnostic Duett Pro sealing device, Vascular Solutions said.
    The study will also focus on qualifying Thrombin-VSI for use in the device maker’s existing line of hemostats, including D-Stat Dry, D-Stat Radial, ThrombiGel and D-Stat Flowable.
    “This conditional approval is an important milestone in the qualification of our new source of thrombin to control our long term supply and cost for our hemostatic devices,” said Vascular Solutions CEO, Howard Root.
    He said the new study would get under way in the third quarter of this year at about 10 US centers.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics